2cureX AB

Research 2cureX AB (2CUREX) on Bullrun: market cap SEK 12.55M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker2CUREX
ExchangeST
CountryDenmark
SectorHealthcare
IndustryBiotechnology
CurrencySEK
Market capSEK 12.55M
Financial periodFY2024
RevenueSEK 0
Net income-SEK 4.55M
Free cash flow-SEK 4.63M

Valuation Snapshot

latest market cap is SEK 12.55M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2024	SEK 0	-SEK 4.55M	-SEK 4.63M	n/a	-0.18	SEK 5.14M	n/a	SEK 4.68M
FY2023	SEK 0	-SEK 38.38M	-SEK 1.95M	n/a	-2.18	SEK 1.46M	n/a	SEK 6.54M
FY2022	SEK 90.00K	-SEK 29.77M	-SEK 28.53M	n/a	-1.69	SEK 44.89M	n/a	SEK 43.03M
FY2021	SEK 0	-SEK 18.94M	-SEK 18.46M	n/a	-1.15	SEK 72.94M	n/a	SEK 74.34M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-27	SEK 12.55M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 SEK.

About 2cureX AB

2cureX AB (publ) operates as a medical technology company in Europe. ts proprietary IndiTreat test family creates various three-dimensional tumoroids derived from fresh samples of colorectal cancer (CRC) tissue that has been obtained from an individual patient's metastatic colorectal cancer. 2cureX AB (publ) was incorporated in 2006 and is based in Landskrona, Sweden.

Related stock research

Denmark stocks Denmark Healthcare stocks A-Z stock index

Other Healthcare stocks

Strategic Partners A/S (1TB0) CESSATECH A/S DK -20 (8GN) FLUOGUIDE A/S DK -1 (96X) ALK-Abelló A/S (ALK-B) Ascendis Pharma A/S (ASND) Bavarian Nordic A/S (BV3A) Evaxion Biotech A/S (EVAX) GENMAB (GE9) Genmab (GMAB) Gubra A/S (GUBRA) Initiator Pharma A/S (INIT) Pharma Equity Group (PEG.CO)

Frequently asked questions

What is 2cureX AB's market cap?

2cureX AB's market capitalization is SEK 12.55M.